TORONTO, ON--(Marketwired - Jan 27, 2014) - Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, is pleased to announce through its wholly-owned subsidiary AllStar Health Brands Inc. and its strategic partner, Vortex Traffic LLC, a nation-wide mass online launch of its newest offering -- TapouT Muscle Explosion, an all-natural muscle strength and growth formula, intended for both pre-and post-workout regimens.
Stephen Blazick, President of Vortex Traffic LLC, stated: "TapouT continues to be Vortex's primary focus due to its scalability potential and is unlike any other partnership we have had. Our team at Vortex is target-focused on launch by mid-February and have isolated over 4,500 web sites we are planning to launch this campaign on. It will be a household name, if it is not already, within months."
Since 2007 Vortex has produced over $140 million in global sales for its clients, primarily in the health and beauty industry.
Dr. Bagi, President of Axxess Pharma stated, "This launch will be a major milestone for Axxess/AllStar, as we have the right partner and an exciting new product all in line with our focus on effective, all-natural products for the active, healthy lifestyle and we have planned our inventory to be able to support upwards of 1,000 sales/day through Vortex Traffic.
About Vortex Traffic:
Vortex Traffic is a leading digital marketing firm based in Las Vegas, Nevada. Vortex specializes in complete campaign management and acquisitions of high performing media.
About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain -- to optimal health management through improved nutritional supplements.
For more information, please visit www.axxesspharmainc.com, or contact Investor Relations at (973) 351-3868.
Safe Harbor Statement
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.